It has been a long journey since we first uncovered defective translation in cancer upon amino acid shortage in 2019 and today where we have been finally able to target cancer cells by adoptive T cell therapy against those aberrant peptides.
Latest posts 5
We are happy to announce that our group is among the three groups from the @NKI_nl that will receive the prestigious @ERC_Research Advanced Grant! This grant will support our goal of detecting and exploiting changes in the protein landscape of cancer.
➡️ bit.ly/4aMY4mi
➡️ bit.ly/4aMY4mi
We are thrilled to enounce the selection of our principle investigator Reuven Agami as a new member of @_knaw for his "series of highly original and high-impact discoveries"!
lnkd.in/d9PxWRnq
lnkd.in/d9PxWRnq
Congratulations to @abhipataskar42 for being awarded the highly prestigious annual AvL prize for the most talented young researcher of the NKI. We are all very proud👏
We are excited to share our recent review published fresh in Molecular Cell. It highlights recent advance on various protein diversification events by mRNA translation in cancer. #cancer #molecularcell #AcademicTwitter #mRNAtranslation #Cell
cell.com/molecular-cell…
www.cell.com Proteome diversification by mRNA translation in cancer In this issue of Molecular Cell, Kochavi et al. review recent findings describing how diverse mRNA translation mechanisms elicit cancer-specific protein diversification. Particular attention is paid... cell.com/molecular-cell…